+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Healthcare Contract Manufacturing Market Size, Share & Trends Analysis Report by Type (Medical Devices, Pharmaceutical), End Use (Medical Device Companies), and Region with Growth Forecasts, 2025-2033- Product Image
Healthcare Contract Manufacturing Market Size, Share & Trends Analysis Report by Type (Medical Devices, Pharmaceutical), End Use (Medical Device Companies), and Region with Growth Forecasts, 2025-2033- Product Image
New

Healthcare Contract Manufacturing Market Size, Share & Trends Analysis Report by Type (Medical Devices, Pharmaceutical), End Use (Medical Device Companies), and Region with Growth Forecasts, 2025-2033

  • PDF Icon

    Report

  • 120 Pages
  • September 2025
  • Region: Global
  • Grand View Research
  • ID: 5415419
REQUEST CUSTOMIZATION
Description Jump to:
The global healthcare contract manufacturing market size was estimated at USD 233.73 Billion in 2025 and is projected to reach USD 566.16 billion by 2033, growing at a CAGR of 11.7% from 2025 to 2033. The market is driven by the expanding biologics and biosimilars market, increasing regulatory complexity, and the commercial success of biologics for clinical use.

Contract manufacturers with established biologics platforms support pharmaceutical companies in scaling up complex biologic drug manufacturing, including monoclonal antibodies, vaccines, and cell and gene therapies. As patents expire for blockbuster biologics, biosimilars gain prominence, creating outsourcing opportunities for CMOs/CDMOs with flexible capacity. Their expertise in process development, large-scale production, and quality management positions them as critical partners in meeting rising global demand for biologics and biosimilars, significantly driving the healthcare contract manufacturing market’s growth.

Furthermore, organizations such as the FDA, EMA, and WHO have strict and changing regulations for the global healthcare industry. A substantial investment in data integrity, quality assurance, and Good Manufacturing Practices (GMP) is necessary to meet manufacturing compliance. Many businesses, particularly new biopharma and medtech enterprises lack the internal infrastructure and knowledge necessary to meet these criteria. A dependable option is provided by contract manufacturers with proven compliance frameworks, regulatory approvals, and inspection histories. Businesses reduce risks, prevent expensive delays, and guarantee quicker market access through outsourcing. Global demand for contract manufacturing partnerships is significantly fueled by the growing complexity of regulations.

The need for pharmaceutical medications and medical equipment is being driven by the increasing frequency of noninvasive surgical operations. OEMs are progressively outsourcing non-core manufacturing tasks in order to handle this growth, which allows for lower labor costs, better capital utilization, increased productivity, and shorter lead times. For pharma companies of all sizes, outsourcing has become a cost-effective strategy, particularly as fixed costs for biologics manufacturing-representing nearly 60-70% of the Cost of Goods Sold (COGS)-remain unavoidable even during idle production periods. This makes outsourcing an economically viable option to balance efficiency, scalability, and cost management in a competitive healthcare landscape.

Furthermore, the adoption of multi-product facilities for biologics manufacturing has demonstrated both economic efficiency and safety, as risks of product carryover are negligible, thereby driving market growth. However, rapid supply chain adaptation is a difficulty for the heavily regulated medical device business. Although the FDA actively monitors and responds to shortages, U.S. manufacturers are not required to notify the agency of any actual or prospective shortages. Aluminum, integrated circuits, lithium-ion batteries, and specialty parts such as platinum, pneumatic fittings, and black body radiation sources are among the items in short supply. According to Medical Product Outsourcing, outsourcing should result in lower costs and a quicker time to market, which is expected to support the expansion of the healthcare CRO market.

Global Healthcare Contract Manufacturing Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, the analyst has segmented the global healthcare contract manufacturing market report based on type, end use, and region:

Type Outlook (Revenue, USD Million, 2021-2033)

  • Medical Devices
  • Pharmaceutical

End Use Outlook (Revenue, USD Million, 2021-2033)

  • Medical Device Companies
  • Pharmaceutical & Biopharmaceutical Companies
  • Others

Regional Outlook (Revenue, USD Million, 2021-2033)

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East & Africa

Why should you buy this report?

  • Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segmental and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listings for you to stay ahead of the curve

This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Research Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Type
1.2.2. End-Use
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased Database
1.4.2. Internal Database
1.4.3. Secondary Sources
1.4.4. Primary Research
1.5. Information Or Data Analysis
1.5.1. Data Analysis Models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity Flow Analysis
1.7.2. Top-Down Analysis
1.7.3. Botton-Up Approach
1.7.4. Multivariate Analysis
1.8. List of Secondary Sources
1.9. List of Abbreviations
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Healthcare Contract Manufacturing Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Expanding Biologics and Biosimilars Market
3.2.1.2. Increasing Regulatory Complexity
3.2.1.3. Commercial Success of Biologics for Clinical Use
3.2.1.4. Commercial Success of Biologics for Clinical Use
3.2.2. Market Restraint Analysis
3.2.2.1. Threat of Information Loss
3.2.2.2. Regulatory and Legal Compliance
3.3. Technology Landscape
3.4. Pricing Model Analysis
3.5. Tariff Impact Analysis
3.6. Value Chain Analysis
3.6.1. Supply Trends
3.6.2. Demand Trends
3.7. Market Analysis Tools
3.7.1. Porter’s Five Force Analysis
3.7.2. PESTEL by SWOT Analysis
Chapter 4. Healthcare Contract Manufacturing Market: Type Estimates & Trend Analysis
4.1. Healthcare Contract Manufacturing Market, by Type: Segment Dashboard
4.2. Healthcare Contract Manufacturing Market, by Type: Movement Analysis
4.3. Healthcare Contract Manufacturing Market Estimates & Forecasts, by Type, 2021-2033 (USD Million)
4.4. Medical Devices
4.4.1. Medical Devices Market Estimates and Forecasts, 2021-2033 (USD Million)
4.4.2. Service
4.4.2.1. Service Market Estimates and Forecasts, 2021-2033 (USD Million)
4.4.2.2. Accessories manufacturing
4.4.2.2.1. Accessories manufacturing Market Estimates and Forecasts, 2021-2033 (USD Million)
4.4.2.3. Assembly manufacturing
4.4.2.3.1. Assembly manufacturing Market Estimates and Forecasts, 2021-2033 (USD Million)
4.4.2.4. Component manufacturing
4.4.2.4.1. Component manufacturing Market Estimates and Forecasts, 2021-2033 (USD Million)
4.4.2.5. Device manufacturing
4.4.2.5.1. Device manufacturing Market Estimates and Forecasts, 2021-2033 (USD Million)
4.4.3. Therapeutic Area
4.4.3.1. Therapeutic Area Market Estimates and Forecasts, 2021-2033 (USD Million)
4.4.3.2. Oncology
4.4.3.2.1. Oncology Market Estimates and Forecasts, 2021-2033 (USD Million)
4.4.3.3. Infectious Diseases
4.4.3.3.1. Infectious Diseases Market Estimates and Forecasts, 2021-2033 (USD Million)
4.4.3.4. Neurological Disorders
4.4.3.4.1. Neurological Disorders Market Estimates and Forecasts, 2021-2033 (USD Million)
4.4.3.5. Cardiovascular Disease
4.4.3.5.1. Cardiovascular Disease Market Estimates and Forecasts, 2021-2033 (USD Million)
4.4.3.6. Metabolic Disorders
4.4.3.6.1. Metabolic Disorders Market Estimates and Forecasts, 2021-2033 (USD Million)
4.4.3.7. Autoimmune Diseases
4.4.3.7.1. Autoimmune Diseases Market Estimates and Forecasts, 2021-2033 (USD Million)
4.4.3.8. Respiratory Diseases
4.4.3.8.1. Respiratory Diseases Market Estimates and Forecasts, 2021-2033 (USD Million)
4.4.3.9. Ophthalmology
4.4.3.9.1. Ophthalmology Market Estimates and Forecasts, 2021-2033 (USD Million)
4.4.3.10. Gastrointestinal Disorders
4.4.3.10.1. Gastrointestinal Disorders Market Estimates and Forecasts, 2021-2033 (USD Million)
4.4.3.11. Hormonal Disorders
4.4.3.11.1. Hormonal Disorders Market Estimates and Forecasts, 2021-2033 (USD Million)
4.4.3.12. Hematological Disorders
4.4.3.12.1. Hematological Disorders Market Estimates and Forecasts, 2021-2033 (USD Million)
4.4.3.13. Others
4.4.3.13.1. Others Market Estimates and Forecasts, 2021-2033 (USD Million)
4.5. Pharmaceutical
4.5.1. Pharmaceutical Market Estimates and Forecasts, 2021-2033 (USD Million)
4.5.2. API/Bulk Drugs
4.5.2.1. API/Bulk Drugs Market Estimates and Forecasts, 2021-2033 (USD Million)
4.5.3. Advanced drug delivery formulations
4.5.3.1. Advanced drug delivery formulations Market Estimates and Forecasts, 2021-2033 (USD Million)
4.5.4. Packaging
4.5.4.1. Packaging Market Estimates and Forecasts, 2021-2033 (USD Million)
4.5.5. Finished dose formulations
4.5.5.1. Finished dose formulations Market Estimates and Forecasts, 2021-2033 (USD Million)
4.5.5.2. Solid
4.5.5.2.1. Solid Market Estimates and Forecasts, 2021-2033 (USD Million)
4.5.5.3. Liquid
4.5.5.3.1. Liquid Market Estimates and Forecasts, 2021-2033 (USD Million)
4.5.5.4. Semi-solid formulations
4.5.5.4.1. Semi-solid formulations Market Estimates and Forecasts, 2021-2033 (USD Million)
Chapter 5. Healthcare Contract Manufacturing Market: End Use Estimates & Trend Analysis
5.1. Healthcare Contract Manufacturing Market, by End Use: Segment Dashboard
5.2. Healthcare Contract Manufacturing Market, by End Use: Movement Analysis
5.3. Healthcare Contract Manufacturing Market Estimates & Forecasts, by End-Use, 2021-2033 (USD Million)
5.4. Medical Device Companies
5.4.1. Medical Device Companies Market Estimates and Forecasts, 2021-2033 (USD Million)
5.5. Pharmaceutical & Biopharmaceutical Companies
5.5.1. Pharmaceutical & Biopharmaceutical Companies Market Estimates and Forecasts, 2021-2033 (USD Million)
5.6. Others
5.6.1. Others Market Estimates and Forecasts, 2021-2033 (USD Million)
Chapter 6. Healthcare Contract Manufacturing Market: Regional Estimates & Trend Analysis
6.1. Regional Market Dashboard
6.2. Regional Market Share Analysis, 2024 & 2033
6.3. North America
6.3.1. North America Market Estimates and Forecasts, 2021-2033 (USD Million)
6.3.2. U.S
6.3.2.1. Key Country Dynamics
6.3.2.2. Competitive Scenario
6.3.2.3. Regulatory Framework
6.3.2.4. U.S. Market Estimates and Forecasts, 2021-2033 (USD Million)
6.3.3. Canada
6.3.3.1. Key Country Dynamics
6.3.3.2. Competitive Scenario
6.3.3.3. Regulatory Framework
6.3.3.4. Canada Market Estimates and Forecasts, 2021-2033 (USD Million)
6.3.4. Mexico
6.3.4.1. Key Country Dynamics
6.3.4.2. Competitive Scenario
6.3.4.3. Regulatory Framework
6.3.4.4. Mexico Market Estimates and Forecasts, 2021-2033 (USD Million)
6.4. Europe
6.4.1. Europe Market Estimates and Forecasts, 2021-2033 (USD Million)
6.4.2. UK
6.4.2.1. Key Country Dynamics
6.4.2.2. Competitive Scenario
6.4.2.3. Regulatory Framework
6.4.2.4. UK Market Estimates and Forecasts, 2021-2033 (USD Million)
6.4.3. Germany
6.4.3.1. Key Country Dynamics
6.4.3.2. Competitive Scenario
6.4.3.3. Regulatory Framework
6.4.3.4. Germany Market Estimates and Forecasts, 2021-2033 (USD Million)
6.4.4. France
6.4.4.1. Key Country Dynamics
6.4.4.2. Competitive Scenario
6.4.4.3. Regulatory Framework
6.4.4.4. France Market Estimates and Forecasts, 2021-2033 (USD Million)
6.4.5. Italy
6.4.5.1. Key Country Dynamics
6.4.5.2. Competitive Scenario
6.4.5.3. Regulatory Framework
6.4.5.4. Italy Market Estimates and Forecasts, 2021-2033 (USD Million)
6.4.6. Spain
6.4.6.1. Key Country Dynamics
6.4.6.2. Competitive Scenario
6.4.6.3. Regulatory Framework
6.4.6.4. Spain Market Estimates and Forecasts, 2021-2033 (USD Million)
6.4.7. Denmark
6.4.7.1. Key Country Dynamics
6.4.7.2. Competitive Scenario
6.4.7.3. Regulatory Framework
6.4.7.4. Denmark Market Estimates and Forecasts, 2021-2033 (USD Million)
6.4.8. Sweden
6.4.8.1. Key Country Dynamics
6.4.8.2. Competitive Scenario
6.4.8.3. Regulatory Framework
6.4.8.4. Sweden Market Estimates and Forecasts, 2021-2033 (USD Million)
6.4.9. Norway
6.4.9.1. Key Country Dynamics
6.4.9.2. Competitive Scenario
6.4.9.3. Regulatory Framework
6.4.9.4. Norway Market Estimates and Forecasts, 2021-2033 (USD Million)
6.5. Asia-Pacific
6.5.1. Asia-Pacific Market Estimates and Forecasts, 2021-2033 (USD Million)
6.5.2. Japan
6.5.2.1. Key Country Dynamics
6.5.2.2. Competitive Scenario
6.5.2.3. Regulatory Framework
6.5.2.4. Japan Market Estimates and Forecasts, 2021-2033 (USD Million)
6.5.3. China
6.5.3.1. Key Country Dynamics
6.5.3.2. Competitive Scenario
6.5.3.3. Regulatory Framework
6.5.3.4. China Market Estimates and Forecasts, 2021-2033 (USD Million)
6.5.4. India
6.5.4.1. Key Country Dynamics
6.5.4.2. Competitive Scenario
6.5.4.3. Regulatory Framework
6.5.4.4. India Market Estimates and Forecasts, 2021-2033 (USD Million)
6.5.5. Australia
6.5.5.1. Key Country Dynamics
6.5.5.2. Competitive Scenario
6.5.5.3. Regulatory Framework
6.5.5.4. Australia Market Estimates and Forecasts, 2021-2033 (USD Million)
6.5.6. Thailand
6.5.6.1. Key Country Dynamics
6.5.6.2. Competitive Scenario
6.5.6.3. Regulatory Framework
6.5.6.4. Thailand Market Estimates and Forecasts, 2021-2033 (USD Million)
6.5.7. South Korea
6.5.7.1. Key Country Dynamics
6.5.7.2. Competitive Scenario
6.5.7.3. Regulatory Framework
6.5.7.4. South Korea Market Estimates and Forecasts, 2021-2033 (USD Million)
6.6. Latin America
6.6.1. Latin America Market Estimates and Forecasts, 2021-2033 (USD Million)
6.6.2. Brazil
6.6.2.1. Key Country Dynamics
6.6.2.2. Competitive Scenario
6.6.2.3. Regulatory Framework
6.6.2.4. Brazil Market Estimates and Forecasts, 2021-2033 (USD Million)
6.6.3. Argentina
6.6.3.1. Key Country Dynamics
6.6.3.2. Competitive Scenario
6.6.3.3. Regulatory Framework
6.6.3.4. Argentina Market Estimates and Forecasts, 2021-2033 (USD Million)
6.7. MEA
6.7.1. MEA Market Estimates and Forecasts, 2021-2033 (USD Million)
6.7.2. South Africa
6.7.2.1. Key Country Dynamics
6.7.2.2. Competitive Scenario
6.7.2.3. Regulatory Framework
6.7.2.4. South Africa Market Estimates and Forecasts, 2021-2033 (USD Million)
6.7.3. UAE
6.7.3.1. Key Country Dynamics
6.7.3.2. Competitive Scenario
6.7.3.3. Regulatory Framework
6.7.3.4. UAE Market Estimates and Forecasts, 2021-2033 (USD Million)
6.7.4. Saudi Arabia
6.7.4.1. Key Country Dynamics
6.7.4.2. Competitive Scenario
6.7.4.3. Regulatory Framework
6.7.4.4. Saudi Arabia Market Estimates and Forecasts, 2021-2033 (USD Million)
6.7.5. Kuwait
6.7.5.1. Key Country Dynamics
6.7.5.2. Competitive Scenario
6.7.5.3. Regulatory Framework
6.7.5.4. Kuwait Market Estimates and Forecasts, 2021-2033 (USD Million)
6.7.6. Qatar
6.7.6.1. Key Country Dynamics
6.7.6.2. Competitive Scenario
6.7.6.3. Regulatory Framework
6.7.6.4. Qatar Market Estimates and Forecasts, 2021-2033 (USD Million)
6.7.7. Oman
6.7.7.1. Key Country Dynamics
6.7.7.2. Competitive Scenario
6.7.7.3. Regulatory Framework
6.7.7.4. Oman Market Estimates and Forecasts, 2021-2033 (USD Million)
Chapter 7. Competitive Landscape
7.1. Key Participant Categorization
7.1.1. Market Leaders
7.1.2. Emerging Players
7.2. Market Share/Assessment Analysis, 2024 (Heat Map Analysis)
7.3. Company Profiles
7.3.1. Nordson Corporation
7.3.1.1. Company Overview
7.3.1.2. Financial Performance
7.3.1.3. Service Benchmarking
7.3.1.4. Strategic Initiatives
7.3.2. Integer Holdings Corporation
7.3.2.1. Company Overview
7.3.2.2. Financial Performance
7.3.2.3. Service Benchmarking
7.3.2.4. Strategic Initiatives
7.3.3. Jabil Inc.
7.3.3.1. Company Overview
7.3.3.2. Financial Performance
7.3.3.3. Service Benchmarking
7.3.3.4. Strategic Initiatives
7.3.4. Viant Technology LLC
7.3.4.1. Company Overview
7.3.4.2. Financial Performance
7.3.4.3. Service Benchmarking
7.3.4.4. Strategic Initiatives
7.3.5. FLEX LTD.
7.3.5.1. Company Overview
7.3.5.2. Financial Performance
7.3.5.3. Service Benchmarking
7.3.5.4. Strategic Initiatives
7.3.6. Celestica Inc
7.3.6.1. Company Overview
7.3.6.2. Financial Performance
7.3.6.3. Service Benchmarking
7.3.6.4. Strategic Initiatives
7.3.7. Sanmina Corporation
7.3.7.1. Company Overview
7.3.7.2. Financial Performance
7.3.7.3. Service Benchmarking
7.3.7.4. Strategic Initiatives
7.3.8. Plexus Corp
7.3.8.1. Company Overview
7.3.8.2. Financial Performance
7.3.8.3. Service Benchmarking
7.3.8.4. Strategic Initiatives
7.3.9. Phillips-Medisize
7.3.9.1. Company Overview
7.3.9.2. Financial Performance
7.3.9.3. Service Benchmarking
7.3.9.4. Strategic Initiatives
7.3.10. West Pharmaceutical Services, Inc.
7.3.10.1. Company Overview
7.3.10.2. Financial Performance
7.3.10.3. Service Benchmarking
7.3.10.4. Strategic Initiatives
7.3.11. Synecco Ltd
7.3.11.1. Company Overview
7.3.11.2. Financial Performance
7.3.11.3. Service Benchmarking
7.3.11.4. Strategic Initiatives
7.3.12. Catalent, Inc.
7.3.12.1. Company Overview
7.3.12.2. Financial Performance
7.3.12.3. Service Benchmarking
7.3.12.4. Strategic Initiatives
7.3.13. Thermo Fisher Scientific Inc.
7.3.13.1. Company Overview
7.3.13.2. Financial Performance
7.3.13.3. Service Benchmarking
7.3.13.4. Strategic Initiatives
7.3.14. Recipharm AB
7.3.14.1. Company Overview
7.3.14.2. Financial Performance
7.3.14.3. Service Benchmarking
7.3.14.4. Strategic Initiatives
7.3.15. Boehringer Ingelheim International GmbH
7.3.15.1. Company Overview
7.3.15.2. Financial Performance
7.3.15.3. Service Benchmarking
7.3.15.4. Strategic Initiatives
7.3.16. Lonza
7.3.16.1. Company Overview
7.3.16.2. Financial Performance
7.3.16.3. Service Benchmarking
7.3.16.4. Strategic Initiatives
7.3.17. Samsung Biologics
7.3.17.1. Company Overview
7.3.17.2. Financial Performance
7.3.17.3. Service Benchmarking
7.3.17.4. Strategic Initiatives
7.3.18. WuXi AppTec
7.3.18.1. Company Overview
7.3.18.2. Financial Performance
7.3.18.3. Service Benchmarking
7.3.18.4. Strategic Initiatives
7.3.19. FUJIFILM Diosynth Biotechnologies
7.3.19.1. Company Overview
7.3.19.2. Financial Performance
7.3.19.3. Service Benchmarking
7.3.19.4. Strategic Initiatives
7.3.20. Cambrex Corporation
7.3.20.1. Company Overview
7.3.20.2. Financial Performance
7.3.20.3. Service Benchmarking
7.3.20.4. Strategic Initiatives
List of Tables
Table 1. List of Secondary Sources
Table 2. List of Abbreviations
Table 3. Global Healthcare Contract Manufacturing Market Estimates and Forecasts, by Type, 2021-2033 (USD Million)
Table 4. Global Healthcare Contract Manufacturing Market Estimates and Forecasts, by End-Use, 2021-2033 (USD Million)
Table 5. North America Healthcare Contract Manufacturing Market Estimates and Forecasts, by Country, 2021-2033 (USD Million)
Table 6. North America Healthcare Contract Manufacturing Market Estimates and Forecasts, by Type, 2021-2033 (USD Million)
Table 7. North America Healthcare Contract Manufacturing Market Estimates and Forecasts, by End-Use, 2021-2033 (USD Million)
Table 8. U.S. Healthcare Contract Manufacturing Market Estimates and Forecasts, by Type, 2021-2033 (USD Million)
Table 9. U.S. Healthcare Contract Manufacturing Market Estimates and Forecasts, by End-Use, 2021-2033 (USD Million)
Table 10. Canada Healthcare Contract Manufacturing Market Estimates and Forecasts, by Type, 2021-2033 (USD Million)
Table 11. Canada Healthcare Contract Manufacturing Market Estimates and Forecasts, by End-Use, 2021-2033 (USD Million)
Table 12. Mexico Healthcare Contract Manufacturing Market Estimates and Forecasts, by Type, 2021-2033 (USD Million)
Table 13. Mexico Healthcare Contract Manufacturing Market Estimates and Forecasts, by End-Use, 2021-2033 (USD Million)
Table 14. Europe Healthcare Contract Manufacturing Market Estimates and Forecasts, by Country, 2021-2033 (USD Million)
Table 15. Europe Healthcare Contract Manufacturing Market Estimates and Forecasts, by Type, 2021-2033 (USD Million)
Table 16. Europe Healthcare Contract Manufacturing Market Estimates and Forecasts, by End-Use, 2021-2033 (USD Million)
Table 17. UK Healthcare Contract Manufacturing Market Estimates and Forecasts, by Type, 2021-2033 (USD Million)
Table 18. UK Healthcare Contract Manufacturing Market Estimates and Forecasts, by End-Use, 2021-2033 (USD Million)
Table 19. Germany Healthcare Contract Manufacturing Market Estimates and Forecasts, by Type, 2021-2033 (USD Million)
Table 20. Germany Healthcare Contract Manufacturing Market Estimates and Forecasts, by End-Use, 2021-2033 (USD Million)
Table 21. France Healthcare Contract Manufacturing Market Estimates and Forecasts, by Type, 2021-2033 (USD Million)
Table 22. France Healthcare Contract Manufacturing Market Estimates and Forecasts, by End-Use, 2021-2033 (USD Million)
Table 23. Italy Healthcare Contract Manufacturing Market Estimates and Forecasts, by Type, 2021-2033 (USD Million)
Table 24. Italy Healthcare Contract Manufacturing Market Estimates and Forecasts, by End-Use, 2021-2033 (USD Million)
Table 25. Spain Healthcare Contract Manufacturing Market Estimates and Forecasts, by Type, 2021-2033 (USD Million)
Table 26. Spain Healthcare Contract Manufacturing Market Estimates and Forecasts, by End-Use, 2021-2033 (USD Million)
Table 27. Denmark Healthcare Contract Manufacturing Market Estimates and Forecasts, by Type, 2021-2033 (USD Million)
Table 28. Denmark Healthcare Contract Manufacturing Market Estimates and Forecasts, by End-Use, 2021-2033 (USD Million)
Table 29. Sweden Healthcare Contract Manufacturing Market Estimates and Forecasts, by Type, 2021-2033 (USD Million)
Table 30. Sweden Healthcare Contract Manufacturing Market Estimates and Forecasts, by End-Use, 2021-2033 (USD Million)
Table 31. Norway Healthcare Contract Manufacturing Market Estimates and Forecasts, by Type, 2021-2033 (USD Million)
Table 32. Norway Healthcare Contract Manufacturing Market Estimates and Forecasts, by End-Use, 2021-2033 (USD Million)
Table 33. Asia-Pacific Healthcare Contract Manufacturing Market Estimates and Forecasts, by Country, 2021-2033 (USD Million)
Table 34. Asia-Pacific Healthcare Contract Manufacturing Market Estimates and Forecasts, by Type, 2021-2033 (USD Million)
Table 35. Asia-Pacific Healthcare Contract Manufacturing Market Estimates and Forecasts, by End-Use, 2021-2033 (USD Million)
Table 36. Japan Healthcare Contract Manufacturing Market Estimates and Forecasts, by Type, 2021-2033 (USD Million)
Table 37. Japan Healthcare Contract Manufacturing Market Estimates and Forecasts, by End-Use, 2021-2033 (USD Million)
Table 38. China Healthcare Contract Manufacturing Market Estimates and Forecasts, by Type, 2021-2033 (USD Million)
Table 39. China Healthcare Contract Manufacturing Market Estimates and Forecasts, by End-Use, 2021-2033 (USD Million)
Table 40. India Healthcare Contract Manufacturing Market Estimates and Forecasts, by Type, 2021-2033 (USD Million)
Table 41. India Healthcare Contract Manufacturing Market Estimates and Forecasts, by End-Use, 2021-2033 (USD Million)
Table 42. Australia Healthcare Contract Manufacturing Market Estimates and Forecasts, by Type, 2021-2033 (USD Million)
Table 43. Australia Healthcare Contract Manufacturing Market Estimates and Forecasts, by End-Use, 2021-2033 (USD Million)
Table 44. Thailand Healthcare Contract Manufacturing Market Estimates and Forecasts, by Type, 2021-2033 (USD Million)
Table 45. Thailand Healthcare Contract Manufacturing Market Estimates and Forecasts, by End-Use, 2021-2033 (USD Million)
Table 46. South Korea Healthcare Contract Manufacturing Market Estimates and Forecasts, by Type, 2021-2033 (USD Million)
Table 47. South Korea Healthcare Contract Manufacturing Market Estimates and Forecasts, by End-Use, 2021-2033 (USD Million)
Table 48. Latin America Healthcare Contract Manufacturing Market Estimates and Forecasts, by Country, 2021-2033 (USD Million)
Table 49. Latin America Healthcare Contract Manufacturing Market Estimates and Forecasts, by Product, 2021-2033 (USD Million)
Table 50. Latin America Healthcare Contract Manufacturing Market Estimates and Forecasts, by End-Use, 2021-2033 (USD Million)
Table 51. Brazil Healthcare Contract Manufacturing Market Estimates and Forecasts, by Type, 2021-2033 (USD Million)
Table 52. Brazil Healthcare Contract Manufacturing Market Estimates and Forecasts, by End-Use, 2021-2033 (USD Million)
Table 53. Argentina Healthcare Contract Manufacturing Market Estimates and Forecasts, by Type, 2021-2033 (USD Million)
Table 54. Argentina Healthcare Contract Manufacturing Market Estimates and Forecasts, by End-Use, 2021-2033 (USD Million)
Table 55. Middle East & Africa Healthcare Contract Manufacturing Market Estimates and Forecasts, by Country, 2021-2033 (USD Million)
Table 56. Middle East & Africa Healthcare Contract Manufacturing Market Estimates and Forecasts, by End-Use, 2021-2033 (USD Million)
Table 57. South Africa Healthcare Contract Manufacturing Market Estimates and Forecasts, by Type, 2021-2033 (USD Million)
Table 58. South Africa Healthcare Contract Manufacturing Market Estimates and Forecasts, by End-Use, 2021-2033 (USD Million)
Table 59. Saudi Arabia Healthcare Contract Manufacturing Market Estimates and Forecasts, by Type, 2021-2033 (USD Million)
Table 60. Saudi Arabia Healthcare Contract Manufacturing Market Estimates and Forecasts, by End-Use, 2021-2033 (USD Million)
Table 61. UAE Healthcare Contract Manufacturing Market Estimates and Forecasts, by Type, 2021-2033 (USD Million)
Table 62. UAE Healthcare Contract Manufacturing Market Estimates and Forecasts, by End-Use, 2021-2033 (USD Million)
Table 63. Kuwait Healthcare Contract Manufacturing Market Estimates and Forecasts, by Type, 2021-2033 (USD Million)
Table 64. Kuwait Healthcare Contract Manufacturing Market Estimates and Forecasts, by End-Use, 2021-2033 (USD Million)
Table 65. Oman Healthcare Contract Manufacturing Market Estimates and Forecasts, by Type, 2021-2033 (USD Million)
Table 66. Oman Healthcare Contract Manufacturing Market Estimates and Forecasts, by End-Use, 2021-2033 (USD Million)
Table 67. Qatar Healthcare Contract Manufacturing Market Estimates and Forecasts, by Type, 2021-2033 (USD Million)
Table 68. Qatar Healthcare Contract Manufacturing Market Estimates and Forecasts, by End-Use, 2021-2033 (USD Million)
List of Figures
Figure 1 Market research process
Figure 2 Information procurement
Figure 3 Primary research pattern
Figure 4 Market research approaches
Figure 5 Market formulation & validation
Figure 6 Commodity flow analysis
Figure 7 Value-chain-based sizing & forecasting
Figure 8 QFD model sizing & forecasting
Figure 9 Bottom-up approach
Figure 10 Market snapshot
Figure 11 Segment snapshot 1
Figure 12 Segment snapshot 2
Figure 13 Competitive landscape snapshot
Figure 14 Parent market outlook, 2024 (USD Billion)
Figure 15 Ancillary market outlook, 2024 (USD Billion)
Figure 16 Healthcare Contract Manufacturing Market Dynamics
Figure 17 Porter’s five forces analysis
Figure 18 PESTEL analysis
Figure 19 Healthcare Contract Manufacturing Market: Type outlook and key takeaways
Figure 20 Healthcare Contract Manufacturing Market: Type movement analysis
Figure 21 Medical Devices Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 22 Service Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 23 Accessories manufacturing Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 24 Assembly manufacturing Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 25 Component manufacturing Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 26 Device manufacturing Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 27 Therapeutic Area Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 28 Oncology Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 29 Infectious Diseases Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 30 Neurological Disorders Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 31 Cardiovascular Disease Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 32 Metabolic Disorders Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 33 Autoimmune Diseases Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 34 Respiratory Diseases Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 35 Ophthalmology Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 36 Gastrointestinal Disorders Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 37 Hormonal Disorders Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 38 Hematological Disorders Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 39 Others Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 40 Pharmaceutical Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 41 API/Bulk Drugs Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 42 Advanced drug delivery formulations Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 43 Packaging Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 44 Finished dose formulations Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 45 Solid Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 46 Liquid Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 47 Semi-solid formulations Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 48 Healthcare Contract Manufacturing Market: End-Use outlook and key takeaways
Figure 49 Healthcare Contract Manufacturing Market: End-Use movement analysis
Figure 50 Medical Device Companies Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 51 Pharmaceutical & Biopharmaceutical Companies Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 52 Others Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 53 Regional Marketplace: Key Takeaways
Figure 54 North America Healthcare Contract Manufacturing Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 55 Key country dynamics
Figure 56 U.S. Healthcare Contract Manufacturing Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 57 Key country dynamics
Figure 58 Canada Healthcare Contract Manufacturing Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 59 Key country dynamics
Figure 60 Mexico Healthcare Contract Manufacturing Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 61 Europe Healthcare Contract Manufacturing Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 62 Key country dynamics
Figure 63 UK Healthcare Contract Manufacturing Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 64 Key country dynamics
Figure 65 Germany Healthcare Contract Manufacturing Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 66 Key country dynamics
Figure 67 France Healthcare Contract Manufacturing Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 68 Key country dynamics
Figure 69 Italy Healthcare Contract Manufacturing Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 70 Key country dynamics
Figure 71 Spain Healthcare Contract Manufacturing Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 72 Key country dynamics
Figure 73 Denmark Healthcare Contract Manufacturing Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 74 Key country dynamics
Figure 75 Sweden Healthcare Contract Manufacturing Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 76 Key country dynamics
Figure 77 Norway Healthcare Contract Manufacturing Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 78 Asia-Pacific Healthcare Contract Manufacturing Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 79 Key country dynamics
Figure 80 Japan Healthcare Contract Manufacturing Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 81 Key country dynamics
Figure 82 China Healthcare Contract Manufacturing Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 83 Key country dynamics
Figure 84 India Healthcare Contract Manufacturing Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 85 Key country dynamics
Figure 86 Australia Healthcare Contract Manufacturing Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 87 Key country dynamics
Figure 88 Thailand Healthcare Contract Manufacturing Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 89 Key country dynamics
Figure 90 South Korea Healthcare Contract Manufacturing Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 91 Latin America Healthcare Contract Manufacturing Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 92 Key country dynamics
Figure 93 Brazil Healthcare Contract Manufacturing Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 94 Key country dynamics
Figure 95 Argentina Healthcare Contract Manufacturing Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 96 MEA Healthcare Contract Manufacturing Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 97 Key country dynamics
Figure 98 South Africa Healthcare Contract Manufacturing Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 99 Key country dynamics
Figure 100 UAE Healthcare Contract Manufacturing Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 101 Key country dynamics
Figure 102 Saudi Arabia Healthcare Contract Manufacturing Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 103 Key country dynamics
Figure 104 Kuwait Healthcare Contract Manufacturing Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 105 Key country dynamics
Figure 106 Qatar Healthcare Contract Manufacturing Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 107 Key country dynamics
Figure 108 Oman Healthcare Contract Manufacturing Market Estimates and Forecasts, 2021-2033 (USD Million)
Figure 109 Key company categorization
Figure 110 Service heat map analysis
Figure 111 Strategic framework

Companies Mentioned

The leading players profiled in this Healthcare Contract Manufacturing market report include:
  • ordson Corporation
  • nteger Holdings Corporation
  • abil Inc.
  • iant Technology LLC
  • LEX LTD.
  • elestica Inc.
  • anmina Corporation
  • lexus Corp.
  • hillips-Medisize
  • est Pharmaceutical Services, Inc.
  • ynecco Ltd
  • atalent, Inc.
  • hermo Fisher Scientific Inc.
  • ecipharm AB
  • oehringer Ingelheim International GmbH
  • onza
  • amsung Biologics
  • uXi AppTec
  • UJIFILM Diosynth Biotechnologies
  • ambrex Corporation

Table Information

Report AttributeDetails
No. of Pages120
PublishedSeptember 2025
Forecast Period2025 - 2033
Estimated Market Value ( USD ) in 2025 $ 233.73 Billion
Forecasted Market Value ( USD ) by 2033 $ 566.16 Billion
Compound Annual Growth Rate11.7%
Regions CoveredGlobal
No. of Companies Mentioned21

Related Topics

Related Reports

Healthcare Contract Manufacturing Market - Global Forecast 2025-2032 - Product Image

Healthcare Contract Manufacturing Market - Global Forecast 2025-2032

  • Report
  • 184 Pages
  • Global
From
Consumer Health Contract Manufacturing Market Size, Share & Trends Analysis Report By Product (Over-the-counter Drugs, Nutritional Supplements, Personal Care Products, Medical Devices), By Service, By End-use, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Consumer Health Contract Manufacturing Market Size, Share & Trends Analysis Report By Product (Over-the-counter Drugs, Nutritional Supplements, Personal Care Products, Medical Devices), By Service, By End-use, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 150 Pages
  • Global
From
Healthcare Contract Research Organization Market Size, Share & Trends Analysis Report By Type (Drug Discovery, Pre-clinical, And Clinical), By Service, By Therapeutic Area, By Molecule, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Healthcare Contract Research Organization Market Size, Share & Trends Analysis Report By Type (Drug Discovery, Pre-clinical, And Clinical), By Service, By Therapeutic Area, By Molecule, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 200 Pages
  • Global
From
Healthcare Digital Experience Platform Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2025 To 2033 - Product Image

Healthcare Digital Experience Platform Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2025 To 2033

  • Report
  • 184 Pages
  • Global
From
Nitinol Contract Manufacturing Service for Medical Market - Global Forecast 2025-2030 - Product Image

Nitinol Contract Manufacturing Service for Medical Market - Global Forecast 2025-2030

  • Report
  • 185 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.